Skip to main content

Adherence to Medication - Predictive Factors in RA

Dec 13, 2021 5:55 pm

The numbers on treatment adherence is disappointingly low in RA, with a number of psychological, communication and logistical factors that outweigh the potentially negative influence of sociodemographic or clinical factors.

A 6-month prospective cohort study of RA patients assessed drug adherence; with one-third each falling into the following treatment groups:

  • 33% on first disease-modifying rheumatic drug (DMARD),
  • 33% on second-line DMARD
  • 33% on biologics

Treatment adherence was defined by a score greater than 80% both in the Compliance Questionnaire in Rheumatology and the Reported Adherence to Medication scale.

From a total of 180 RA patients (77% women, mean age 60.8) the overall prevalence was 59.1% (95% CI 48.1% to 71.8%).

Those on biologics had a higher adherence and perceived a higher medication need.

Those on on second-line DMARDs had experienced more adverse events.

Factors affecting adherence included:

  • type of treatment prescribed (second-line DMARDs OR=5.22, and biologics OR=3.76)
  • agreement on treatment (OR=4.57)
  • having received information on treatment adaptation (OR=1.42)
  • physician perception of patient trust (OR=1.58).

Disease activity and other clinical variables were not as influential. 

The author has no conflicts of interest to disclose related to this subject

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.